William K. Heiden

2019

In 2019, William K. Heiden earned a total compensation of $4.9M as President and Chief Executive Officer at AMAG Pharmaceuticals, a 2% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$474,311
Option Awards$546,714
Salary$791,265
Stock Awards$3,044,790
Other$11,200
Total$4,868,280

Heiden received $3M in stock awards, accounting for 63% of the total pay in 2019.

Heiden also received $474.3K in non-equity incentive plan, $546.7K in option awards, $791.3K in salary and $11.2K in other compensation.

Rankings

In 2019, William K. Heiden's compensation ranked 2,297th out of 13,971 executives tracked by ExecPay. In other words, Heiden earned more than 83.6% of executives.

ClassificationRankingPercentile
All
2,297
out of 13,971
84th
Division
Manufacturing
831
out of 5,701
85th
Major group
Chemicals And Allied Products
267
out of 2,200
88th
Industry group
Drugs
215
out of 1,886
89th
Industry
Pharmaceutical Preparations
158
out of 1,398
89th

Pay ratio

William K. Heiden's Pay$4,868,280
Median Employee's Pay$189,221
Pay Ratio

26

to 1

In 2019, the annual total compensation of William K. Heiden was $4,868,280.

The annual total compensation of the median employee at AMAG Pharmaceuticals was $189,221.

The ratio of William K. Heiden's pay to the pay of median employee was therefore 26 to one.

Source: SEC filing on April 29, 2020.

Heiden's colleagues

We found four more compensation records of executives who worked with William K. Heiden at AMAG Pharmaceuticals in 2019.

2019

Edward Myles

AMAG Pharmaceuticals

Chief Financial Officer

2019

Joseph Vittiglio

AMAG Pharmaceuticals

General Counsel

2019

Anthony Casciano

AMAG Pharmaceuticals

Chief Commercial Officer

2019

Julie Krop

AMAG Pharmaceuticals

Chief Medical Officer

News

You may also like